Tradestie Institutional Equity Comparison Engine

DCTH vs VREX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DCTH Overall Edge

DCTH Captures Institutional Edge (3โ€“1 Pillars ยท 3โ€“7 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while VREX counters with relative strength in Valuation. Fundamentally, DCTH trades at N/M Forward P/E with 5.2% operating margin (+70.7% YoY revenue) versus VREX at 16.9x Forward P/E and 8.3% operating margin (+3.7% YoY). In options structure, DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro) against VREX sits in UNCLASSIFIED (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VREX
DCTH N/M vs VREX 16.9x Fwd P/E
Growth & Margin Winner DCTH
Op Margin 5.2% vs 8.3% ยท YoY +70.7% vs +3.7%
Momentum & Technical Winner DCTH
1Y +128.6% vs +51.5% ยท 52W Pos 80% vs 96%
Options & Structure Winner DCTH
BREAKOUT (43rd %ile IV) vs UNCLASSIFIED (18th %ile IV)
DCTH NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap $743.8M
1M Return +39.77%
1Y Return +128.57%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 50.0 Fund 38.0 Flow 60.0 Mom 54.0
VREX NASDAQ
Varex Imaging Corporation Common Stock
Electronic Components, Nec
$18.21
+0.64% 1D
Market Cap $771.6M
1M Return -1.06%
1Y Return +51.54%
Forward P/E 16.9x
Unified AI Score
50.0 / 100 HOLD
Tech 47.0 Fund 50.0 Flow 50.0 Mom 56.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DCTH +128.57% VREX +51.54% Spread: +77.03 pp (DCTH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DCTH TTM Op. Margin: 5.2% VREX TTM Op. Margin: 8.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DCTH vs VREX. Trailing 12-month operating profitability (DCTH 5.2% vs VREX 8.3%) and valuation multiples (DCTH N/M vs VREX 16.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DCTH (3) vs VREX (7)
Institutional Metric DCTH VREX Criterion Row Winner
Market Capitalization Scale $743.8M $771.6M Larger Scale VREX
Trailing P/E Ratio Valuation 133.6x 34.3x Lower Multiple VREX
Forward P/E Ratio Valuation N/M 16.9x Lower Multiple VREX
Revenue Growth (YoY) Growth +70.7% +3.7% Higher Growth DCTH
Operating Margin (TTM) Profitability 5.2% 8.3% Higher Margin VREX
Net Profit Margin Profitability 6.0% 2.6% Higher Margin DCTH
Return on Equity (ROE) Capital Efficiency 5.4% 4.6% Higher ROE DCTH
52-Week Range Position Momentum 80% ($8โ€“$23) 96% ($9โ€“$19) Stronger Trend VREX
Beta / 30D Volatility Risk Regime 1.63ฮฒ ยท 131% Vol 0.74ฮฒ ยท 5% Vol Lower Realized Risk VREX
Unified Institutional Score Composite Signal 35.9 / 100 (SELL) 50.0 / 100 (HOLD) Higher Composite VREX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DCTH vs VREX Buy Guide
DCTH BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DCTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VREX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live VREX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DCTH nor VREX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.